ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,495Medicare Part D Prescriptions Filled, Including Refills

Rank: 103 out of 783

$777K Total Retail Price of All Prescriptions

Rank: 104 out of 783

327 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
66% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 327 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

20% of this provider’s 327 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

2% of this provider’s 12,200 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$58 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

41 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
OMEPRAZOLE 548 495 1 6
POTASSIUM CHLORIDE 490 476 2 16
NAMENDA 468 433 3 32
FUROSEMIDE 406 380 4 7
HYDROCODONE-ACETAMINOPHEN 398 364 S3 5 2
LEVOTHYROXINE SODIUM 385 351 6 1
LISINOPRIL 381 363 7 4
DONEPEZIL HCL 360 360 8 24
WARFARIN SODIUM 272 237 9 10
AMLODIPINE BESYLATE 255 242 10 5
METOPROLOL TARTRATE 237 226 11 9
SIMVASTATIN 236 206 12 3
ESCITALOPRAM OXALATE 212 209 13 54
POLYETHYLENE GLYCOL 3350 207 183 14 43
LEVOFLOXACIN 174 163 15 75
DIVALPROEX SODIUM 153 142 16 72
METFORMIN HCL 151 134 17 8
SERTRALINE HCL 151 148 17 22
GLIPIZIDE 149 149 19 71
MIRTAZAPINE 144 137 20 52
PRENATAL PLUS 140 128 21 279
BUMETANIDE 135 122 22 131
RANITIDINE HCL 135 129 22 44
IPRATROPIUM-ALBUTEROL 128 121 24 110
CITALOPRAM HBR 128 106 24 19
ALLOPURINOL 118 116 26 31
ALENDRONATE SODIUM 118 118 26 25
GABAPENTIN 116 88 28 15
ATENOLOL 113 97 29 17
EXELON 113 82 29 109
ISOSORBIDE MONONITRATE ER 105 104 31 40
ZOLPIDEM TARTRATE 105 91 31 23
DIGOXIN 104 103 33 61
METOCLOPRAMIDE HCL 100 73 34 121
ROPINIROLE HCL 99 98 35 74
QUETIAPINE FUMARATE 98 81 36 79
CIPROFLOXACIN HCL 97 95 37 62
PREDNISONE 94 79 38 36
METOPROLOL SUCCINATE 93 92 39 13
CYMBALTA 92 78 40 35
NYSTATIN 86 72 41 106
PANTOPRAZOLE SODIUM 81 74 42 30
TAMSULOSIN HCL 81 80 42 26
HYDROCHLOROTHIAZIDE 79 74 44 12
CARVEDILOL 79 72 44 21
FENTANYL 77 70 S2 46 65
OLANZAPINE 75 75 47 108
NYSTOP 74 64 48 231
CARBIDOPA-LEVODOPA 74 74 48 88
HYDRALAZINE HCL 73 72 50 78
LIDODERM 72 63 51 132
MELOXICAM 72 68 51 37
DOXYCYCLINE HYCLATE 70 66 53 112
PLAVIX 70 64 53 51
NOVOLOG 68 68 55 81
TRAZODONE HCL 67 66 56 39
GLIPIZIDE ER 66 54 57 84
SUCRALFATE 65 59 58 190
CLOPIDOGREL 62 52 59 29
FLUTICASONE PROPIONATE 61 55 60 46
VENLAFAXINE HCL ER 60 36 61 100
AMOX TR-POTASSIUM CLAVULANATE 59 53 62 128
MEGESTROL ACETATE 59 56 R 62 238
LANTUS 57 57 64 38
LEVETIRACETAM 55 42 65 89
ATORVASTATIN CALCIUM 54 48 66 11
CEFDINIR 53 44 67 210
CYCLOBENZAPRINE HCL 52 45 R 68 63
LEXAPRO 52 51 68 181
RISPERIDONE 52 44 68 67
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 19, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.